Vangapandu SN[au] - Search Results

Year	Number of Results
2005	1
2006	6
2008	1
2011	2
2012	1
2022	0

1

Rational design, synthesis and biological evaluations of amino-noscapine: a high affinity tubulin-binding noscapinoid.

Naik PK, Chatterji BP, Vangapandu SN, Aneja R, Chandra R, Kanteveri S, Joshi HC. Naik PK, et al. Among authors: vangapandu sn. J Comput Aided Mol Des. 2011 May;25(5):443-54. doi: 10.1007/s10822-011-9430-4. Epub 2011 May 5. J Comput Aided Mol Des. 2011. PMID: 21544622

2

Synthesis and biological evaluation of a cyclic ether fluorinated noscapine analog.

Aneja R, Vangapandu SN, Joshi HC. Aneja R, et al. Among authors: vangapandu sn. Bioorg Med Chem. 2006 Dec 15;14(24):8352-8. doi: 10.1016/j.bmc.2006.09.012. Epub 2006 Sep 27. Bioorg Med Chem. 2006. PMID: 17008104

3

Rational design of the microtubule-targeting anti-breast cancer drug EM015.

Aneja R, Lopus M, Zhou J, Vangapandu SN, Ghaleb A, Yao J, Nettles JH, Zhou B, Gupta M, Panda D, Chandra R, Joshi HC. Aneja R, et al. Among authors: vangapandu sn. Cancer Res. 2006 Apr 1;66(7):3782-91. doi: 10.1158/0008-5472.CAN-05-2962. Cancer Res. 2006. PMID: 16585205 Free article.

4

In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).

Naik PK, Lopus M, Aneja R, Vangapandu SN, Joshi HC. Naik PK, et al. Among authors: vangapandu sn. J Comput Aided Mol Des. 2012 Feb;26(2):233-47. doi: 10.1007/s10822-011-9508-z. Epub 2011 Dec 15. J Comput Aided Mol Des. 2012. PMID: 22170255

5

Multidrug resistance-associated protein-overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent.

Aneja R, Liu M, Yates C, Gao J, Dong X, Zhou B, Vangapandu SN, Zhou J, Joshi HC. Aneja R, et al. Among authors: vangapandu sn. Cancer Res. 2008 Mar 1;68(5):1495-503. doi: 10.1158/0008-5472.CAN-07-1874. Cancer Res. 2008. PMID: 18316614

6

Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011.

Aneja R, Zhou J, Vangapandu SN, Zhou B, Chandra R, Joshi HC. Aneja R, et al. Among authors: vangapandu sn. Blood. 2006 Mar 15;107(6):2486-92. doi: 10.1182/blood-2005-08-3516. Epub 2005 Nov 10. Blood. 2006. PMID: 16282340 Free PMC article.

7

Recent patents on proteases and kinases as anti-infective agents: a review.

Vangapandu SN, Aneja R, Chandra R, Joshi HC. Vangapandu SN, et al. Recent Pat Antiinfect Drug Discov. 2006 Jun;1(2):209-24. doi: 10.2174/157489106777452674. Recent Pat Antiinfect Drug Discov. 2006. PMID: 18221146 Review.

8

Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.

Aneja R, Vangapandu SN, Lopus M, Viswesarappa VG, Dhiman N, Verma A, Chandra R, Panda D, Joshi HC. Aneja R, et al. Among authors: vangapandu sn. Biochem Pharmacol. 2006 Aug 14;72(4):415-26. doi: 10.1016/j.bcp.2006.05.004. Epub 2006 May 10. Biochem Pharmacol. 2006. PMID: 16780803

9

Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and T-cell lymphoma.

Aneja R, Vangapandu SN, Lopus M, Chandra R, Panda D, Joshi HC. Aneja R, et al. Among authors: vangapandu sn. Mol Pharmacol. 2006 Jun;69(6):1801-9. doi: 10.1124/mol.105.021899. Epub 2006 Mar 3. Mol Pharmacol. 2006. PMID: 16517755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results